RESEARCH IN PULMONARY HYPERTENSION
"PHA's research program has yielded an explosion of understanding about PH that was not known before."
- John Newman, MD, Vanderbilt University Medical Center
Twenty years ago there were no pulmonary hypertension treatments available. Through focused research there are now eight PH-specific treatments with more in development. But our ultimate wish is for a cure, and that is why PHA will continue to support the work of researchers until the day when no one suffers from PH.
PHA’s Research Program
In just a little under a decade, PHA’s Research Program has committed more than $15 million for PH research by leveraging partnerships with the National Heart, Lung, and Blood Institute (NHLBI), and the Foundation of the American Thoracic Society (ATS). We have supported over 70 promising researchers through four independently reviewed, cutting-edge research programs.
Read more and apply for one of PHA’s research grants
Learn about other PH research opportunities
Stay informed about ongoing clinical research pertaining to evaluation and treatment of pulmonary hypertension through PHA's PH clinical trial listings, and be sure to post information about the PH clinical trial work you are doing.
Explore PH clinical trial listings or post information about your clinical trial